Geir Almås is the Executive Chairman of SoftOx Solutions, a medtech and clinical-stage pharmaceutical company based in Oslo, Norway.
Geir Almås is the Executive Chairman of SoftOx Solutions, a medtech and clinical-stage pharmaceutical company based in Oslo, Norway. Almås became a co-founder of the Group in 2008 and served as CEO for a decade. SoftOx is developing a new class of antimicrobials with the goal of reducing the spread of infection and the emergence of antimicrobial resistance.
Almås has previously worked for five years as an auditor for Coopers & Lybrand (now PwC) and nine years in governance, risk management, and compliance (GRC), including seven years as a risk manager for KLP Asset Management. Prior to joining SoftOx Solutions, Almås has since 2004 worked with business development in Norway and Poland, including five years as CEO and part-owner in Polfarm Sp. z o.o. Almås has a broad network both in Norway and internationally. He holds a Master of Science in business from BI Norwegian Business School and he is authorized as a Chartered Accountant ( NHH - Norwegian School of Economics).
Chairman of SoftOx Solutions, Norwegian Business School